What is Next-Generation Sequencing Market?
Next-generation sequencing (NGS), alternatively known as high-throughput sequencing, allows sequencing of millions of DNA molecules simultaneously. This method is useful in the field of personalized medicine, genetic diseases and clinical diagnostics as it offers high throughput option with ability to perform sequencing for multiple individual at the same time. The NGS machine or NGS sequencer is flexible enough to operate tasks such as whole –genome sequencing (WGS), targeted sequencing and transcriptome analysis. The Global Next-Generation Sequencing market is expected to grow at a CAGR of 18.64% from (2019-2024) and market size is projected to reach at USD 15.87 Billion by 2024.
The market study is being classified by Type (Pre-Sequencing Products & Services, NGS Consumables, Platforms, & Services for Platforms, Sequencing Services and NGS Data Analysis, Storage, and Management), by Application (Diagnostics, Cancer Diagnostics, Infectious Disease Diagnostics, Reproductive Health Diagnostics, Other Diagnostic Applications, Drug Discovery, Agricultural and Animal Research and Other Applications) and major geographies with country level break-up.
10x Genomics (United States), Agilent Technologies, Inc. (United States), Beckman Coulter (A Subsidiary of Danaher), Becton, Dickinson and Company (United States), BGI (China), Eurofins Scientific (Luxembourg), F. Hoffmann-La Roche AG (Switzerland), Genewiz (United States), Illumina, Inc. (United States), Macrogen, Inc. (South Korea) and Oxford Nanopore Technologies, Ltd. (United States) are some of the key players profiled in the study. Additionally, the Players which are also part of the research are Pacific Biosciences of California, Inc., Perkinelmer, Inc., Thermo Fisher Scientific Inc. and Qiagen N.V..
Research Analyst at AMA predicts that United States Players will contribute to the maximum growth of Global Next-Generation Sequencing market throughout the predicted period.
Analyst at AMA have segmented the market study of Global Next-Generation Sequencing market by Type, Application and Region.
On the basis of geography, the market of Next-Generation Sequencing has been segmented into South America (Brazil, Argentina, Rest of South America), Asia Pacific (China, Japan, India, South Korea, Taiwan, Australia, Rest of Asia-Pacific), Europe (Germany, France, Italy, United Kingdom, Netherlands, Rest of Europe), MEA (Middle East, Africa), North America (United States, Canada, Mexico). North America region held largest market share in the year 2018. Additionally, the rising demand from SMEs and various industry verticals gives enough cushion to market growth.
- Technical Advancement in NGS platform
- Ability to Provide Cost Effective Solution
- Development in Portable Sequencing Technology
- Adoption and Integration of Advanced LIMS (Laboratory Information Management System) Real-Time Tracking Method
- Lack of Budget in Emerging Economies
- Lack of Awareness About NGS Technology
- Favorable Government Initiatives
- Incorporation of Big Data
- Issue Related to Ethics
- Problem Associated With Interpretation of Complex Data
Recently in March 2018, ARUP and metagenomics company IDbyDNA, Inc. launched Explify Respiratory which is an NGS test for respiratory infections that helps physicians while diagnosing patients with pneumonia and other respiratory diseases. Using nucleic acid the test identifies over 200 common and rare bacteria and viruses.
In April 2018, Food and Drug Administration (FDA) finalized a guidance document, Considerations for Design, Development, and Analytical Validation of Next Generation Sequencing (NGS)-Based In Vitro Diagnostics (IVDs) Intended to Aid in the Diagnosis of Suspected Germline Diseases, in efforts to accelerate the establishment of a regulatory approach for next generation sequencing (NGS) testing. FDA has provided a step toward integrating NGS into clinical practice, the document has rekindled the debate about t
Key Target Audience
NGS equipment manufacturers, vendors, and distributors, NGS sequencing service companies, NGS bioinformatics/data analysis companies, Research laboratories and academic institutes, Venture capitalists and other government funding organizations, Research and consulting firms, Healthcare institutions (hospitals and diagnostic clinics), Pharmaceutical and biotechnology companies, Contract manufacturing organizations (CMOs) and Contract research organizations (CROs)
Customization in the Report Available:
The Study can be customized to meet your requirements. Please connect with our representative, who will ensure you get a report that suits your needs.
Data related to EXIM [Export- Import], production & consumption by country or regional level break-up can be provided based on client request**
** Confirmation on availability of data would be informed prior purchase